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Abstract
Introduction: The aim of this study was to estimate forearm bone mineral density (BMD) and bone mineral content (BMC) using single-
energy X-ray absorptiometry (SXA) in a group of Polish women that included both pre- and post-menopausal subjects.
Material and methods: The study was carried out in a cohort of 1,122 otherwise healthy women with no history of previous fractures.
Results: We showed a gradual decline of BMD and BMC with age, and the presence of suspected correlations of densitometric results with
age and selected anthropometric parameters.
Conclusions: Our study confirmed the utility of densitometric screening using forearm SXA measurements. These measurements dis-
criminated clearly between pre- and post-menopausal subjects. Densitometric results correlated negatively with age and age at meno-
pause, but positively with anthropometric indices related to body and skeletal size. Age was the greatest factor in terms of impact on bone
loss. (Pol J Endocrinol 2011; 62 (1): 8–13)
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Streszczenie
Wstęp: Celem pracy była ocena gęstości mineralnej kości (BMD, bone mineral density) i zawartości tkanki kostnej (BMC, bone mineral con-
tent) przedramienia za pomocą metody SXA w licznej grupie polskich kobiet zarówno przed, jak i po menopauzie.
Materiał i metody: Badanie przeprowadzono w grupie 1122 zdrowych kobiet bez złamań.
Wyniki: Wykazano stopniowe obniżanie się wartości BMD i BMC wraz z wiekiem i obecność spodziewanych zależności wyników badań
densytometrycznych od wieku i wybranych parametrów antropometrycznych.
Wnioski: Wyniki badania potwierdziły przydatność skriningu densytometrycznego przedramienia metodą SXA (single X-ray absorptiome-
try). Pomiary różnicowały wyraźnie pacjentki przed menopauzą od pomenopauzalnych. Wyniki densytometrii korelowały negatywnie
z wiekiem i okresem czasu po menopauzie, a pozytywnie ze wskaźnikami antropometrycznymi zależnymi od wielkości ciała i kośćca.
Czynnikiem o największym wpływie na ubytek kości był wiek. (Endokrynol Pol 2011; 62 (1): 8–13)
Słowa kluczowe: osteoporoza, menopauza, przedramię, SXA
Introduction
Osteoporosis is an important public health problem. In
post-menopausal women, a lack of oestrogen leads to
the stimulation of a bone resorption process which over-
comes bone formation. The  consequence is bone mass
loss [1, 2]. Lowered bone mass can be an important risk
factor in osteoporotic fractures [3–5]. It has been esti-
mated that about 75 million women in Europe, the USA
and Japan suffer from osteoporosis [6]. Polish data
shows a prevalence of osteoporosis based on lumbar
spine densitometry in 18.4%; femoral neck 14.8%; total
hip 2.4%; and forearm 17.2% in peri- and post-meno-
pausal women [7, 8]. The most important clinical con-
sequences of osteoporosis are fractures. There are esti-
mated to be about 20,000 proximal femur fractures in
Polish women each year [9]. Statistics regarding excess
mortality following osteoporotic fractures are clear [10].
Axial skeleton densitometry using dual-energy
X-ray absorptiometry (DXA) is a widely used method
of confirming a diagnosis of osteoporosis and estimat-
ing potential fracture risk [5, 11]. Peripheral bone stud-
ies are useful for screening purposes, but their results
must be verified by proximal femur or lumbar spine exa-
mination and clinical risk factor assessment before the
best therapy can be established. Among peripheral tech-
niques, single-energy X-ray absorptiometry (SXA) is
used when axial densitometry is not available. Other
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peripheral methods are peripheral DXA (pDXA), quan-
titative ultrasound (QUS) or peripheral quantitative
computed tomography (pQCT) [12–15].
The aim of our study was to estimate forearm BMD
and BMC using SXA in a substantial group of Polish
women that included both pre- and post-menopausal
subjects.
Material and methods
The study was carried out in 1,122 otherwise healthy
women. The women had no history of previous frac-
tures, no known causes of secondary osteoporosis, and
had not received osteoporosis-focused therapy. They
were recruited from an urban population following
advertisements in the local press. They were divided
into two groups: group I comprised 315 women yet to
experience the menopause, and group II comprised
807 post-menopausal women. The clinical characteris-
tics of the women studied are set out in Table I. Sub-
jects were also divided according to age: there  were
50 women aged under 40, 319 women aged 40–49,
488 women aged 50–59, 228 women aged 60–69, and
37 women aged 70 and above (Table II).
Forearm densitometry was measured using the SXA
method with Osteometer DTX-100 apparatus (Osteome-
ter A/S, Rodovre, Denmark). The non-dominant forearm
was placed in a water bath, with X-ray source emitted
energy of 29 keV. The BMD and the BMC of the radius
and the ulna in the distal and ultradistal parts of the
bones were measured. The results are presented as BMC
in g, BMD as g/cm2, and as percentage of peak values
(young adult), age-matched, T-score and Z-score. All
studies were performed by one experienced operator.
Statistical analysis was performed using Statistica for
Windows. Student’s t-test and correlation analysis us-
ing Pearson’s test were applied. The level of statistical
significance was set at p < 0.05. Analysis of the selected
parameters (age, age at menopause, body mass, BMI,
height) influence on BMD and BMC was carried out
using stepwise multiple regression.
Results
The results of SXA densitometry differed statistically
significantly among the groups studied. There were sta-
tistically significant higher values of both distal and ul-
tradistal BMC and BMD expressed as units measured,
percentage of age-matched and reference age values,
Z-score and T-score values in the premenopausal wom-
en than in the post-menopausal ones (Table III).
When subsequent age ranges (decades) were anal-
ysed, the differences were also very clear, in parallel
with ageing (Table IV). In particular, the differences
Table I. Clinical characteristics of studied women
Tabela I. Charakterystyka kliniczna badanych kobiet
Parameter Group I (315)  mean ± SD Group II (807) mean ± SD p-value
Age (years) 44.52 ± 5.29 58.3 ± 6.59 0.00000
Height [cm] 162.1 ± 5.1 160.4 ± 6.4 0.000033
Weight [kg] 64.77 ± 10.99 67.42 ± 11.76 0.00059
BMI [kg/m2] 24.64 ± 3.97 26.3 ± 6.39 0.000021
Age at menopause (years) – 48.95 ± 4.66 –
Table II. Clinical characteristics in the subgroups of subjects divided according to age
Tabela II. Charakterystyka kliniczna podgrup badanych podzielonych w zależności od wieku
Parameter Age ranges (number of women)
< 40 (50) 40–49 (319) 50–59 (488) 60–69 (228) > 69 (37)
mean ± SD  mean ± SD  mean ± SD  mean ± SD  mean ± SD
Age (years) 34.9 ± 5.87 46.46 ± 2.48 55.4 ± 2.85 64.63 ± 2.6 73.7 ± 3.12
Height [cm] 161.9 ± 6.2 162.2 ± 5.1 160.6 ± 5.2 15 9.5 ± 8.5 161.0 ± 4.7
Weight [kg] 59.3 ± 10.24 66.35 ± 11.16 66.87 ± 11.66 67.97 ± 11.98 68.86 ± 10.5
BMI [kg/m2] 22.67 ± 3.7 25.2 ± 4.01 25.91 ± 4.42 27.08 ± 9.74 26.59 ± 3.82
Age at menopause (years) – 45.72 ± 3.09 49.32 ± 4.15 49.7 ± 4.89 51.6 ± 4.06
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were statistically significant when the younger group
(those in their fourth and fifth decades) was compared
to older subjects (sixth, seventh and eighth decades).
Paradoxically, some densitometric parameters were
higher in fifth decade patients than in fourth decade
patients (Table IV).
In the entire group, and in the post-menopausal
subjects, there were statistically significant (p < 0.05)
negative correlations between age and distal BMC
(r = –0.39 and –0.37, respectively) and between age and
ultradistal BMD (r = –0.48 and –0.43, respectively).
These were not observed in pre-menopausal subjects.
In the entire group, and in the post-menopausal sub-
jects, there were statistically significant (p < 0.05) nega-
tive correlations between years since menopause and
distal BMC (r = –0.39 and –0.32, respectively), and be-
tween years since menopause and ultradistal BMD
(r = –0.47 and –0.36, respectively). In almost all the
groups, there were positive correlations between height,
body mass and BMI on the one side, and densitometric
parameters studied on the other side (Table V).
When we analysed the above mentioned correla-
tions according to particular age group, we found no
correlation between age at menopause and densitomet-
ric measurements in any decade of post-menopasual
patients. Only in the sixth decade were there negative
correlations between current age and both distal BMC
and ultradistal BMD (r = –0.19 and –0.22, respectively).
A very high negative correlation was present between
age and ultradistal BMD in the oldest group (r = –0.72).
The correlation coefficients between years since meno-
pause and densitometric measurements were highest
in the oldest subjects’ decade, and lowest in early post-
menopausal patients. Anthropometric parameters in
most cases correlated positively with densitometric
measurements. The highest correlations were observed
between body mass and BMI and distal BMC in the old-
est group (r = 0.58 and 0.54). They were absent regard-
ing ultradistal BMD in this decade. Correlations be-
tween height and densitometric measurements were
rare and rather weak (Table VI).
In all post-menopausal women there were negative
correlations between age and distal BMC T-score and
ultradistal BMD T-score (r = –0.39 and –0.44, respec-
tively), and between years since menopause and above
mentioned T-score values (r = –0.33 and –0.36, respec-
Table III. Results of forearm densitometry in pre- and post-menopausal women
Tabela III. Wyniki badania densytometrycznego przedramienia kobiet przed i po menopauzie
Measurement Pre-menopausal mean ± SD Post-menopausal mean ± SD p-value
Distal BMC [g] 3.20 ± 0.43 2.85 ± 0.54 0.000000
Distal BMC Z-score –0.29 ± 0.91 –0.15 ± 1.03 0.024
Distal BMC T-score –0.26 ± 0.91 –1.02 ± 1.14 0.0000
Distal BMD Z-score 0.22 ± 0.81 0.01 ± 1.13 0.0010
Distal BMD T-score –0.23 ± 0.827 –1.27 ± 1.27 0.00
Ultradistal BMC [g] 1.19 ± 0.64 1.06 ± 0.57 0.00134
Ultradistal BMD (g/cm2] 0.40 ± 0.06 0.33 ± 0.07 0.00
Ultradistal BMD Z-score 0.64 ± 1.21 0.42 ± 1.38 0.0203
Ultradistal BMD T-score 0.62 ± 1.22 –0.69 ± 1.55 0.00
Table IV. Results of forearm densitometry in age groups (decades)
Tabela IV. Wyniki badania densytometrycznego przedramienia w grupach wiekowych (dekady)
Measurement < 40 years 40–49 years 50–59 years 60–69 years > 69 years
mean ± SD  mean ± SD  mean ± SD  mean ± SD  mean ± SD
Distal BMC [g] 3.18 ± 0.52 3.21 ± 0.41 2.94 ± 0.49 2.62 ± 0.54 2.41 ± 0.56
Distal BMC T-score –0.30 ± 1.12 –0.23 ± 0.87 –0.80 ± 1.02 –1.54 ± 1.13 -1.95 ± 1.21
Distal BMD (g/cm2) 0.49 ± 0.15 0.48 ± 0.09 0.34 ± 0.23 0.38 ± 0.09 0.36 ± 0.17
Distal BMD T-score –0.29 ± 1.05 –0,33 ± 1.01 –0.98 ± 1.08 –1.90 ± 1.31 –2.68 ± 1.21
Ultradistal BMC [g] 1.32 ± 0.63 1.15 ± 0.64 1.07 ± 0.60 1.04 ± 0.51 0.97 ± 0.42
Ultradistal BMD [g/cm2] 0.39 ± 0.06 0.40 ± 0.05 0.35 ± 0.07 0.30 ± 0.07 0.28 ± 0.06
Ultradistal BMD T-score 0.53 ± 1.49 0.63 ± 1.15 0.38 ± 1.39 –1.50 ± 1.49 –1.82 ± 1.41
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tively). The correlation coefficients were highest in the
oldest decade subjects. We found some correlations be-
tween anthropometric parameters and T-scores (more
often regarding distal BMC than ultradistal BMD), and
these mainly in the oldest subjects (Table VII).
In our subjects, age was recognised as the factor with
the greatest influence on densitometric results. The fol-
lowing formulae assessing the influences of the param-
eters studied on distal BMC results were calculated:
Distal BMC = 0.082 – 0.51*age +0.23*height +
+ 0.125*body mass + 0.135*BMI + 0.158 age at me-
nopause (for entire group), R2 = 0.302, SEE = 0.449,
p < 0.000001;
Distal BMC = 1.335 – 0.427*age + 0.168*height +
+ 0.186*body mass + 0.08*age at menopause (for post-
-menopausal group), corrected R2 = 0.273, SEE = 0.463,
p < 0.0001.
Discussion
We have analysed SXA densitometry in a substantial
group of Polish post- and pre-menopausal women.
Unsurprisingly, the results of densitometry were high-
er in pre-menopausal women compared to post-meno-
Table V. Correlation coefficients between age, anthropometric
data and densitometric results in subjects studied
Tabela V. Współczynniki korelacji między wiekiem i danymi
antropometrycznymi a wynikami badania densytome-
trycznego
  Distal Ultradistal
BMC BMD
Entire group
Age –0.39 –0.48
Height 0.30 0.13
Body mass 0.26 0.13
BMI 0.16 0.10
Age at menopause –0.12 –0.16
Years since menopause –0.39 –0.47
Post-menopausal
Age –0.37 –0.43
Height 0.24 NS
Body mass 0.31 0.20
BMI 0.24 0.19
Age at menopause 0.04 NS
Years since menopause –0.32 –0.36
Pre-menopausal
Age NS NS
Height 0.40 0.5
Body mass 0.26 0.16
BMI 0.12 NS
Table VI. Correlation coefficients between age, anthropo-
metric data and densitometric results in particular decades
of post-menopausal subjects studied
Tabela VI. Współczynniki korelacji między wiekiem
i danymi antropometrycznymi a wynikami badania densy-
tometrycznego w poszczególnych dekadach wiekowych
badanych kobiet po menopauzie
  Distal Ultradistal
BMC  BMD
Post-menopausal
Age –0.37 –0.42
Height 0.24 0.08
Body mass 0.31 0.21
BMI 0.24 0.19
Age at menopause NS NS
Years since menopause –0.32 –0.36
Age > 69
Age NS –0.72
Height NS NS
Body mass 0.58 NS
BMI 0.54 NS
Age at menopause NS NS
Years since menopause –0.56 –0.59
Age 60–69
Age –0.18 NS
Height 0.26 0.15
Body mass 0.48 0.40
BMI 0.44 0.40
Age at menopause NS NS
Years since menopause –0.20 NS
Age 50–59
Age –0.19 –0.22
Height 0.19 NS
Body mass 0.27 0.15
BMI 0.21 0.16
Age at menopause NS NS
Years since menopause –0.13 –0.18
Age < 50
Age NS NS
Height 0.39 NS
Body mass 0.26 0.14
BMI 0.12 0.11
pausal subjects. Similarly, there was an almost uniform
decline with ageing. Only when pre-menopausal pa-
tients were compared to early post-menopausal ones,
were some different trends observed.
There have been no such extensive measurements
of the Polish Lower Silesian population previously.
A similar Bulgarian study, carried out on an even larger
population, showed a presence of osteoporosis assessed
by SXA densitometry of 20.45% and osteopenia of 32.5%
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in the studied female population aged 50 and above
[12]. This is similar to other data from Poland, when
Dobreńko et al. examined urban women from the north
of our country using SXA method. The presence of os-
teoporosis was 17.2% in their entire studied group. The
authors pointed to a gradual increase in the percentage
of osteoporotic results; from 8% in the sixth decade,
through 30% in the seventh decade, up to 55% in the
eighth decade of life of women studied [7]. Similar re-
sults were observed in a French study (the OFELY co-
hort) when DXA measurements were used [16]. We did
not perform such a calculation regarding osteoporosis
assessment by densitometry in our group, because ac-
cording to International Society of Clinical Densitome-
try guidelines, peripheral densitometry should not be
used for the routine diagnosis of osteoporosis based on
BMD measurements. This can instead be done using
DXA assessment of axial skeleton — proximal femur
and/or lumbar spine [17], although in the past, forearm
bone densitometry has also been used to predict os-
teoporotic fractures [18, 19]. It has been shown to be
mostly evident in the 50-69 age range, when single pho-
ton gamma absorptiometry (SPA) was used [18]. More-
over, the role of densitometry for the initiation of a prop-
er anti-osteoporosis therapy has diminished recently,
according to the FRAX calculator; based on clinical fac-
tors, the femoral neck BMD result could be applied, but
it is not necessary for the estimation of osteoporotic frac-
tures risk [11].
We have analysed the possible relations between
densitometric results on the one side, and age, age at
menopause and some anthropometric parameters on
the other side. For post-menopausal subjects, negative
correlations of ultradistal BMC/BMD and current age
were shown. Interestingly, it was not observed in pre-
menopausal women. Similarly, negative correlations of
distal BMC/ultradistal BMD and time since menopause
were evident. On the contrary, in almost all subgroups,
positive correlations between height, body mass and
BMI on the one side, and densitometric parameters
studied on the other side, were noted. Such correlations
confirm a gradual decline of forearm bone mass and
density with ageing in our subjects. This reflects physi-
ological age-related post-menopausal bone loss [1, 2, 18].
It is interesting that the highest correlations were ob-
served between body mass and BMI and distal BMC in
the oldest group of our subjects, but they were absent
regarding ultradistal BMD in patients within this de-
cade of life. This may be explained by the fact that mea-
surements were carried out in different sites composed
of various bone tissue at distal and ultradistal sites of
the forearm [13, 20].
Multiple regression analysis shows age to be the fac-
tor with the greatest influence on densitometric results
and bone loss in our subjects. It was shown regarding
distal BMC, especially in the oldest groups (analysis not
shown).
Conclusions
Our study confirms the utility of densitometric screening
using forearm SXA measurements. These measurements
discriminate clearly between pre- and post-menopausal
subjects. Densitometric results correlate negatively with
age and age at menopause, but positively with selected
anthropometric indices related to body and skeletal size.
Age is the factor of greatest impact on bone loss.
Table VII. Correlation coefficients between age, anthro-
pometric data and T-score values in particular decades of post-
-menopausal subjects studied
Tabela VII. Współczynniki korelacji między wiekiem
i danymi antropometrycznymi a wynikiem T-score w po-
szczególnych dekadach wiekowych kobiet po menopauzie
  T-score T-score
distal BMC ultradistal
BMD
Post-menopausal
Age –0.39 –0.44
Height 0.24 NS
Body mass 0.31 0.20
BMI 0.24 0.19
Years since menopause –0.33 –0.36
Age > 69
Age NS –0.72
Height NS NS
Body mass 0.58 NS
BMI 0.53 NS
Years since menopause –0.56 –0.59
Age 60–69
Age –0.18 NS
Height 0.21 NS
Body mass 0.46 NS
BMI 0.44 0.39
Years since menopause –0.21 NS
Age 50–59
Age –0.20 –0.23
Height 0.21 NS
Body mass 0.29 0.15
BMI 0.22 0.16
Years since menopause –0.13 –0.19
Age < 50
Age NS NS
Height 0.40 NS
Body mass 0.25 NS
BMI NS NS
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